Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Hemply Balance Holding

0.03 SEK

Less than 1K followers

HMPLY

Nordic SME

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hemply Balance Holding

20212022202320242025
Revenue2.34.72.11.20.8
growth-%102.7 %-55.0 %-44.8 %-27.8 %
EBITDA-12.0-6.0-3.6-0.6-0.5
EBIT-25.1-6.6-3.6-0.6-0.5
Profit before taxes-25.1-9.9-3.6-0.6-0.5
Net income-25.1-9.9-3.6-0.6-0.5
EPS-3.69-1.28-0.32-0.010.00
Dividend0.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

20212022202320242025
EBITDA-%-521.4 %-129.3 %-170.5 %-52.6 %-56.1 %
EBIT-%-1,088.7 %-141.3 %-170.5 %-53.4 %-56.4 %
ROE-744.7 %-380.0 %-973.0 %-52.1 %-68.4 %
ROI-457.8 %-289.7 %-230.8 %-44.9 %-50.7 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.